1. Yang, Xiangyu, Li, Jie, Hu, Xinyao, Tang, Jia, Ma, Qilin. 2022. Identification of PFKFB2 as a key gene for the transition from acute to old myocardial infarction in peripheral blood. In Frontiers in cardiovascular medicine, 9, 993579. doi:10.3389/fcvm.2022.993579. https://pubmed.ncbi.nlm.nih.gov/36561770/
2. Si, Shucheng, Liu, Hongyan, Xu, Lu, Zhan, Siyan. 2024. Identification of novel therapeutic targets for chronic kidney disease and kidney function by integrating multi-omics proteome with transcriptome. In Genome medicine, 16, 84. doi:10.1186/s13073-024-01356-x. https://pubmed.ncbi.nlm.nih.gov/38898508/
3. Liu, Furong, Wei, Xiaoli, Chen, Zhanhong, Hu, Peishan, Jin, Ying. 2023. PFKFB2 is a favorable prognostic biomarker for colorectal cancer by suppressing metastasis and tumor glycolysis. In Journal of cancer research and clinical oncology, 149, 10737-10752. doi:10.1007/s00432-023-04946-1. https://pubmed.ncbi.nlm.nih.gov/37311985/
4. Heine-Suñer, D, Díaz-Guillén, M A, Lange, A J, Rodríguez de Córdoba, S. . Sequence and structure of the human 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase heart isoform gene (PFKFB2). In European journal of biochemistry, 254, 103-10. doi:. https://pubmed.ncbi.nlm.nih.gov/9652401/
5. Yun, Hye Jin, Li, Min, Guo, Dong, Lu, Zhimin, Lee, Jong-Ho. 2023. AMPK-HIF-1α signaling enhances glucose-derived de novo serine biosynthesis to promote glioblastoma growth. In Journal of experimental & clinical cancer research : CR, 42, 340. doi:10.1186/s13046-023-02927-3. https://pubmed.ncbi.nlm.nih.gov/38098117/
6. Yang, Hui, Wang, Xinzhi, Blanco-Gómez, Adrián, Perez-Losada, Jesus, Mao, Jian-Hua. 2024. A susceptibility gene signature for ERBB2-driven mammary tumour development and metastasis in collaborative cross mice. In EBioMedicine, 106, 105260. doi:10.1016/j.ebiom.2024.105260. https://pubmed.ncbi.nlm.nih.gov/39067134/
7. Camargo Barros-Filho, Mateus, Barreto Menezes de Lima, Larissa, Bisarro Dos Reis, Mariana, Kowalski, Luiz Paulo, Rogatto, Silvia Regina. 2019. PFKFB2 Promoter Hypomethylation as Recurrence Predictive Marker in Well-Differentiated Thyroid Carcinomas. In International journal of molecular sciences, 20, . doi:10.3390/ijms20061334. https://pubmed.ncbi.nlm.nih.gov/30884810/
智鼠故事 
